HOME >> BIOLOGY >> NEWS
Universities to share technologies to fight hunger in developing countries; improve domestic crops

A group of leading U.S. public sector agricultural research institutions has agreed to allow access to each other's current and future patented agricultural technologies and is exploring ways to ensure that new licensing agreements allow for technologies to be used to fight global hunger and to boost the domestic agricultural sector.

The agreement will accelerate research and development to improve staple crop varieties like rice, cassava, sorghum and potatoes essential to resource-poor farmers in developing countries who depend on small farm plots and face severe and very fundamental problems, such as poor agricultural soils, drought, plant diseases and pests. Low production is a perennial threat to resourcepoor farming families and an important factor contributing to the chronic undernourishment of about 800 million people worldwide.

The agreement will also benefit the U.S. agricultural sector by speeding up research, development and commercialization of specialty crops like tomatoes, lettuce and grapes for characteristics including improved nutritional value, better disease-resistance and reduced environmental impact. These and other specialty crops, which are grown in specific regions rather than across broad areas involving tens of millions of acres like wheat and corn, are important to states' economies.

A new initiative, the Public-Sector Intellectual Property Resource for Agriculture, or PIPRA, has been established to collaborate in managing participating institutions' intellectual property. PIPRA will explore and encourage best practices in IP licensing that will result in greater access to agricultural inventions for subsistence and specialty crop applications. It will also establish a mechanism for information sharing so that researchers at those institutions can more easily determine what public sector-owned technologies exist, who holds the rights, and if the technology has been licensed, to whom and under what terms. '"/>

Contact: George Soule
gsoule@rockfound.org
212-852-8456
Rockefeller Foundation
10-Jul-2003


Page: 1 2 3

Related biology news :

1. Universities to compete in second annual autonomous underwater vehicle (AUV) competition
2. Research At New England Universities And Industries Facing Uncertain Future Under Proposed R&D Reductions
3. Bone, enamel, dentine, milk & saliva share gene family
4. K-State researchers share $1 million grant to study insect pests
5. Cross-species comparison reveals shared features between tumorigenesis and organogenesis
6. Scientists discover that metastases share a similar genetic profile to their primary tumour
7. Drug addiction, learning share common brain protein
8. Monkey talk, human speech share left-brain processing
9. Lions share of the best of Asias progressive minds in science and medicine convene
10. UC Riverside is part of new initiative to share patented research on agriculture
11. New grants enable biomedical research centers to share science with their communities

Post Your Comments:
(Date:4/2/2015)... , April 2, 2015 ... touch fingerprint sensor FPC1025 from the distributor World Peace ... commence during Q2 2015 although the major part of ... sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of ...
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ... Biometrics - Global Strategic Business Report" report to their offering. ... Voice Biometrics in US$ Thousands by the following Segments: Face Biometrics, ... US, Canada , Japan , ... Middle East & Africa , ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
(Date:4/20/2015)... MENLO PARK, Calif. , April 20, ... DMPI) (DelMar and the Company), a biopharmaceutical company ... in new orphan drug indications, today announced promising ... of the American Association for Cancer Research ... lead product candidate VAL-083 (dianhydrogalactitol) to ...
(Date:4/20/2015)... , April 20, 2015  Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal and metabolic diseases, today ... has joined the Company,s Board of Directors. Dr. ... board level experience, having built and led teams ... regulatory approval and into healthcare systems globally. ...
(Date:4/20/2015)... , April 20, 2015  "Everybody is affected ... do to patients is frankly brutal. We,ve got to ... a cancer ward, or witnessed a loved one or ... witnessed firsthand the devastation chemotherapy and other treatments cause ... people want to give up and succumb to the ...
(Date:4/20/2015)... Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of ... results for the fourth quarter and full year ended ... Highlights(Compared to the fourth quarter 2013) , Quarterly ... from $22.9 million in the prior year period. Excluding ... vaccine of $0.1 million in the fourth quarter of ...
Breaking Biology Technology:DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18
Cached News: